The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Research Report 2025

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426329

No of Pages : 83

Ask Your Query

Synopsis

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.

The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.

Report Scope

The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi Pasteur
  • CSL Limited
  • Emergent Biosolutions
  • Serum Institute of India
  • Johnson & Johnson

Segment by Type

  • Pediatric Hepatitis B (CHO) Vaccine
  • Adult Hepatitis B (CHO) Vaccine

Segment by Application

  • Hospitals
  • Clinics

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
1.1 Product Overview and Scope of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type
1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Pediatric Hepatitis B (CHO) Vaccine
1.2.3 Adult Hepatitis B (CHO) Vaccine
1.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application
1.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 2019-2030
1.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2019-2030
1.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competition by Manufacturers
2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Type & Application
2.7 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation and Trends
2.7.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue
2.7.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Retrospective Market Scenario by Region
3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2019-2030
3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2019-2024
3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2025-2030
3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019-2030
3.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019-2024
3.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2025-2030
3.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
3.4.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
3.4.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
3.5.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
3.5.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2030)
4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2024)
4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2025-2030)
4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2030)
4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2024)
4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2025-2030)
4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)
5.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2024)
5.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2025-2030)
5.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)
5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2024)
5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2025-2030)
5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 CSL Limited
6.5.1 CSL Limited Corporation Information
6.5.2 CSL Limited Description and Business Overview
6.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.5.5 CSL Limited Recent Developments/Updates
6.6 Emergent Biosolutions
6.6.1 Emergent Biosolutions Corporation Information
6.6.2 Emergent Biosolutions Description and Business Overview
6.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.6.5 Emergent Biosolutions Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis
7.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
7.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Marketing
7.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels
7.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
7.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
8 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Dynamics
8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
8.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges
8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock